Kinetics and Cellular Site of Glycolipid Loading Control the Outcome of Natural Killer T Cell Activation

Jin S. Im; Pooja Arora; Gabriel Bricard; Alberto Molano; Manjunatha M. Venkataswamy; Ian Baine; Elliot S. Jerud; Michael F Goldberg; Andres Baena; Karl O A Yu; Rachel M. Ndonye; Amy R. Howell; Weiming Yuan; Peter Cresswell; Young tae Chang; Petr A. Illarionov; Gurdyal S. Besra; Steven A. Porcelli

doi:10.1016/j.immuni.2009.03.022

Kinetics and Cellular Site of Glycolipid Loading Control the Outcome of Natural Killer T Cell Activation

Jin S. Im, Pooja Arora, Gabriel Bricard, Alberto Molano, Manjunatha M. Venkataswamy, Ian Baine, Elliot S. Jerud, Michael F Goldberg, Andres Baena, Karl O A Yu, Rachel M. Ndonye, Amy R. Howell, Weiming Yuan, Peter Cresswell, Young tae Chang, Petr A. Illarionov, Gurdyal S. Besra, Steven A. Porcelli

Research output: Contribution to journal › Article › peer-review

152 Scopus citations

Abstract

CD1d-restricted natural killer T cells (NKT cells) possess a wide range of effector and regulatory activities that are related to their ability to secrete both T helper 1 (Th1) cell- and Th2 cell-type cytokines. We analyzed presentation of NKT cell activating α galactosylceramide (αGalCer) analogs that give predominantly Th2 cell-type cytokine responses to determine how ligand structure controls the outcome of NKT cell activation. Using a monoclonal antibody specific for αGalCer-CD1d complexes to visualize and quantitate glycolipid presentation, we found that Th2 cell-type cytokine-biasing ligands were characterized by rapid and direct loading of cell-surface CD1d proteins. Complexes formed by association of these Th2 cell-type cytokine-biasing αGalCer analogs with CD1d showed a distinctive exclusion from ganglioside-enriched, detergent-resistant plasma membrane microdomains of antigen-presenting cells. These findings help to explain how subtle alterations in glycolipid ligand structure can control the balance of proinflammatory and anti-inflammatory activities of NKT cells.

Original language	English (US)
Pages (from-to)	888-898
Number of pages	11
Journal	Immunity
Volume	30
Issue number	6
DOIs	https://doi.org/10.1016/j.immuni.2009.03.022
State	Published - Jun 19 2009
Externally published	Yes

Bibliographical note

Funding Information:
This work was supported by NIH grants AI45889 (S.A.P.) and AI057519 (A.R.H.). G.S.B. is a former Lister Institute-Jenner Research Fellow and received support from the Medical Research Council (U.K.), the Wellcome Trust (084923/B/08/7), a Royal Society Wolfson Research Merit Award, and the James Bardrick Research Chair. K.O.A.Y. was supported by the Medical Scientist Training Program of the Albert Einstein College of Medicine, E.S.J. received a Howard Hughes Medical Institute Training Fellowship, and M.G. was supported by NIH Training Grant 5T32CA009173. The authors acknowledge technical support from the Einstein Analytical Imaging and Flow Cytometry Core Laboratories supported by the NCI funded Einstein Cancer Center (CA13330) and the Einstein Center for AIDS Research (AI51519). S.A.P. is a paid consultant for Vaccinex, Inc. (Rochester, NY).

Keywords

CELLIMMUNO
MOLIMMUNO

Access

10.1016/j.immuni.2009.03.022

OpenUrl availability

Full text

Cite this

Im, J. S., Arora, P., Bricard, G., Molano, A., Venkataswamy, M. M., Baine, I., Jerud, E. S., Goldberg, M. F., Baena, A., Yu, K. O. A., Ndonye, R. M., Howell, A. R., Yuan, W., Cresswell, P., Chang, Y. T., Illarionov, P. A., Besra, G. S., & Porcelli, S. A. (2009). Kinetics and Cellular Site of Glycolipid Loading Control the Outcome of Natural Killer T Cell Activation. Immunity, 30(6), 888-898. https://doi.org/10.1016/j.immuni.2009.03.022

Im, JS, Arora, P, Bricard, G, Molano, A, Venkataswamy, MM, Baine, I, Jerud, ES, Goldberg, MF, Baena, A, Yu, KOA, Ndonye, RM, Howell, AR, Yuan, W, Cresswell, P, Chang, YT, Illarionov, PA, Besra, GS & Porcelli, SA 2009, 'Kinetics and Cellular Site of Glycolipid Loading Control the Outcome of Natural Killer T Cell Activation', Immunity, vol. 30, no. 6, pp. 888-898. https://doi.org/10.1016/j.immuni.2009.03.022

@article{dae403d4dd7e4138adb943c49f1e0549,

title = "Kinetics and Cellular Site of Glycolipid Loading Control the Outcome of Natural Killer T Cell Activation",

abstract = "CD1d-restricted natural killer T cells (NKT cells) possess a wide range of effector and regulatory activities that are related to their ability to secrete both T helper 1 (Th1) cell- and Th2 cell-type cytokines. We analyzed presentation of NKT cell activating α galactosylceramide (αGalCer) analogs that give predominantly Th2 cell-type cytokine responses to determine how ligand structure controls the outcome of NKT cell activation. Using a monoclonal antibody specific for αGalCer-CD1d complexes to visualize and quantitate glycolipid presentation, we found that Th2 cell-type cytokine-biasing ligands were characterized by rapid and direct loading of cell-surface CD1d proteins. Complexes formed by association of these Th2 cell-type cytokine-biasing αGalCer analogs with CD1d showed a distinctive exclusion from ganglioside-enriched, detergent-resistant plasma membrane microdomains of antigen-presenting cells. These findings help to explain how subtle alterations in glycolipid ligand structure can control the balance of proinflammatory and anti-inflammatory activities of NKT cells.",

keywords = "CELLIMMUNO, MOLIMMUNO",

author = "Im, {Jin S.} and Pooja Arora and Gabriel Bricard and Alberto Molano and Venkataswamy, {Manjunatha M.} and Ian Baine and Jerud, {Elliot S.} and Goldberg, {Michael F} and Andres Baena and Yu, {Karl O A} and Ndonye, {Rachel M.} and Howell, {Amy R.} and Weiming Yuan and Peter Cresswell and Chang, {Young tae} and Illarionov, {Petr A.} and Besra, {Gurdyal S.} and Porcelli, {Steven A.}",

note = "Funding Information: This work was supported by NIH grants AI45889 (S.A.P.) and AI057519 (A.R.H.). G.S.B. is a former Lister Institute-Jenner Research Fellow and received support from the Medical Research Council (U.K.), the Wellcome Trust (084923/B/08/7), a Royal Society Wolfson Research Merit Award, and the James Bardrick Research Chair. K.O.A.Y. was supported by the Medical Scientist Training Program of the Albert Einstein College of Medicine, E.S.J. received a Howard Hughes Medical Institute Training Fellowship, and M.G. was supported by NIH Training Grant 5T32CA009173. The authors acknowledge technical support from the Einstein Analytical Imaging and Flow Cytometry Core Laboratories supported by the NCI funded Einstein Cancer Center (CA13330) and the Einstein Center for AIDS Research (AI51519). S.A.P. is a paid consultant for Vaccinex, Inc. (Rochester, NY). ",

year = "2009",

month = jun,

day = "19",

doi = "10.1016/j.immuni.2009.03.022",

language = "English (US)",

volume = "30",

pages = "888--898",

journal = "Immunity",

issn = "1074-7613",

publisher = "Cell Press",

number = "6",

}

TY - JOUR

T1 - Kinetics and Cellular Site of Glycolipid Loading Control the Outcome of Natural Killer T Cell Activation

AU - Im, Jin S.

AU - Arora, Pooja

AU - Bricard, Gabriel

AU - Molano, Alberto

AU - Venkataswamy, Manjunatha M.

AU - Baine, Ian

AU - Jerud, Elliot S.

AU - Goldberg, Michael F

AU - Baena, Andres

AU - Yu, Karl O A

AU - Ndonye, Rachel M.

AU - Howell, Amy R.

AU - Yuan, Weiming

AU - Cresswell, Peter

AU - Chang, Young tae

AU - Illarionov, Petr A.

AU - Besra, Gurdyal S.

AU - Porcelli, Steven A.

N1 - Funding Information: This work was supported by NIH grants AI45889 (S.A.P.) and AI057519 (A.R.H.). G.S.B. is a former Lister Institute-Jenner Research Fellow and received support from the Medical Research Council (U.K.), the Wellcome Trust (084923/B/08/7), a Royal Society Wolfson Research Merit Award, and the James Bardrick Research Chair. K.O.A.Y. was supported by the Medical Scientist Training Program of the Albert Einstein College of Medicine, E.S.J. received a Howard Hughes Medical Institute Training Fellowship, and M.G. was supported by NIH Training Grant 5T32CA009173. The authors acknowledge technical support from the Einstein Analytical Imaging and Flow Cytometry Core Laboratories supported by the NCI funded Einstein Cancer Center (CA13330) and the Einstein Center for AIDS Research (AI51519). S.A.P. is a paid consultant for Vaccinex, Inc. (Rochester, NY).

PY - 2009/6/19

Y1 - 2009/6/19

N2 - CD1d-restricted natural killer T cells (NKT cells) possess a wide range of effector and regulatory activities that are related to their ability to secrete both T helper 1 (Th1) cell- and Th2 cell-type cytokines. We analyzed presentation of NKT cell activating α galactosylceramide (αGalCer) analogs that give predominantly Th2 cell-type cytokine responses to determine how ligand structure controls the outcome of NKT cell activation. Using a monoclonal antibody specific for αGalCer-CD1d complexes to visualize and quantitate glycolipid presentation, we found that Th2 cell-type cytokine-biasing ligands were characterized by rapid and direct loading of cell-surface CD1d proteins. Complexes formed by association of these Th2 cell-type cytokine-biasing αGalCer analogs with CD1d showed a distinctive exclusion from ganglioside-enriched, detergent-resistant plasma membrane microdomains of antigen-presenting cells. These findings help to explain how subtle alterations in glycolipid ligand structure can control the balance of proinflammatory and anti-inflammatory activities of NKT cells.

AB - CD1d-restricted natural killer T cells (NKT cells) possess a wide range of effector and regulatory activities that are related to their ability to secrete both T helper 1 (Th1) cell- and Th2 cell-type cytokines. We analyzed presentation of NKT cell activating α galactosylceramide (αGalCer) analogs that give predominantly Th2 cell-type cytokine responses to determine how ligand structure controls the outcome of NKT cell activation. Using a monoclonal antibody specific for αGalCer-CD1d complexes to visualize and quantitate glycolipid presentation, we found that Th2 cell-type cytokine-biasing ligands were characterized by rapid and direct loading of cell-surface CD1d proteins. Complexes formed by association of these Th2 cell-type cytokine-biasing αGalCer analogs with CD1d showed a distinctive exclusion from ganglioside-enriched, detergent-resistant plasma membrane microdomains of antigen-presenting cells. These findings help to explain how subtle alterations in glycolipid ligand structure can control the balance of proinflammatory and anti-inflammatory activities of NKT cells.

KW - CELLIMMUNO

KW - MOLIMMUNO

UR - http://www.scopus.com/inward/record.url?scp=66949155720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66949155720&partnerID=8YFLogxK

U2 - 10.1016/j.immuni.2009.03.022

DO - 10.1016/j.immuni.2009.03.022

M3 - Article

C2 - 19538930

AN - SCOPUS:66949155720

SN - 1074-7613

VL - 30

SP - 888

EP - 898

JO - Immunity

JF - Immunity

IS - 6

ER -

Kinetics and Cellular Site of Glycolipid Loading Control the Outcome of Natural Killer T Cell Activation

Abstract

Bibliographical note

Keywords

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this